| Literature DB >> 24369898 |
Maarten E Witte1, Don J Mahad2, Hans Lassmann3, Jack van Horssen4.
Abstract
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. Current treatments are very effective in reducing the neuroinflammatory attack, but fail to significantly halt disease progression and associated loss of neuronal tissue. In recent years, it has become increasingly clear that dysfunctional mitochondria are important contributors to damage and loss of both axons and neurons. Observations in animal and histopathological studies suggest that infiltrating leukocytes and activated microglia play a central role in neuronal mitochondrial dysfunction. This review provides a comprehensive overview on the current knowledge regarding mitochondrial dysfunction in MS. Importantly, more insight into the cause and consequences of impaired mitochondrial function provide a basis for mitochondrial-targeted medicine to combat progressive MS.Entities:
Keywords: mitochondria; multiple sclerosis; neurodegeneration; neuroinflammation; oxidative stress
Mesh:
Year: 2013 PMID: 24369898 DOI: 10.1016/j.molmed.2013.11.007
Source DB: PubMed Journal: Trends Mol Med ISSN: 1471-4914 Impact factor: 11.951